Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (3054)	12/4/2014 2:33:27 PM
From: tuck	Respond to of 3202

Good call. Only sold 1/4 of a large position (still largest by a long way), so I've been enjoying the rebound well enough. Roubini says our asset bubble has another year or so, thus buying biotech dips and then reassessing a year from now looks plausible. The devil in the details of entry and exit, as always. But I got good entries on some other issues. Given today's reaction, looks as though approval baked in at this price. So next dip level . . . high $40s? (ducking) Cheers, Tuck